Saves the questions and what to expect into your notes, next to the visit they belong to.
Keep this study
Lead
University of Colorado, Boulder
With
National Cancer Institute (NCI)
Age
18–90
Sex
FEMALE
Healthy volunteers
Accepted
You may be eligible if
1. Women in Colorado treated for Stage 0 to III estrogen receptor-positive breast cancer who have completed primary cancer treatment (surgery, chemotherapy, and/or radiation) and within the past 2.5 years, have been prescribed anti-hormonal therapy
2. Take their anti-hormonal therapy medication at least occasionally and have at least 1 more year left on their prescription
3. Report at least 1 factor that makes taking their anti-hormonal therapy medication difficult
4. Have internet access
Clareo Health | The REACH Study: A Novel Values-Based Intervention to Increase Endocrine Therapy Adherence Among Breast Cancer Survivors
